This is why the BOD is incompetent. A statement that would provide some understanding of the USPTO developments would have been proactive, allowing shareholder an opportunity to better understand ramifications of 336. Instead, the company is silent. A position that has been a hallmark of the BOD. This is not a surprise, but an affirmation of the management inability to confront the issues at hand.